Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
US12344661B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2019 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Oct 31, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a molecular complex for targeting the antigen towards cells comprising antigens, including at least one antigen associated with at least two ligands of surface molecules of cells comprising antigens, said complex including at least one first ligand of a sulphated sugar of the glycosaminoglycan family and a second ligand of a specific surface molecule of cells comprising antigens, and said first ligand being covalently bonded with said antigen and/or said second ligand.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.